You are here: Industry Insights > Products Guide > Urgent Sourcing Needs of【en-CPhI.cn】2018.05.14

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Avatrombopag Maleate

BioHub® Magnetic Separator

Avatrombopag

Ursodeoxycholic acid

Troxerutin

CytoLinX® BRTF Single-use Top-driven Bioreactor Bag

Urgent Sourcing Needs of【en-CPhI.cn】2018.05.14

en-cphi.cnMay 14, 2018

Tag: urgent , Sourcing Needs , en-CPhI.cn

Favorites

【CPhI.cn】provides the free-of-charge One-to-One Matching Service every week. Your dedicated client service officer collects your sourcing needs and searches suitable suppliers for you to improve your sourcing efficiency greatly.

The validity of the sourcing needs lasts one week.

If your company could provide the following health care medical supplies, you can email the product name to Miki. She will reply you with the detailed information including the buyers' contact information.

Contact Person: Miki

Email: Miki.Zhou@ubmsinoexpo.com

Tel: 86-21-33392254

Name of the product	CAS No.	Quantity	Delivery Period	Payment	Details	Date	Country
Cetereth-25, Cetereth-30					Quantity: 200kg.Quality Standards:Packing: 25kg. BagsPlace of Origin: KoreaPurity:Standard:Detailed Description:	2018/5/6	United State
(3S,10S,13S,14S,17R)-4,4,10,13,14-pentamethyl-17-[(2S)-6-methyl-5-methylidene-heptan-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol	566-14-3				Quantity: 500mgQuality Standards: AvailablePacking:SecuredPlace of Origin:Purity:90-100%Standard:Detailed Description:	2018/5/4	Philippine
Sodium acetylide(Na2(C2)) (6CI,7CI,8CI,9CI)	2881-62-1				Quantity: 10g-100gQuality Standards: powderPacking: bottlePlace of Origin: PoznanPurity: 90%+Standard: Detailed Description: high pure, argon protection	2018/5/4	Poland
Copper 1,3-diphenyl-1,3-propanedionate	14405-48-2				Quantity: 50-100 gmQuality Standards:Packing: Place of Origin: Purity: Standard: Detailed Description: I am looking for small amount of above material for R & D.Kindly send me the quote and lead time.Thank you,shailendra negi	2018/5/3	United State
2-ACRYLAMIDO-2-METHYLPROPANE SULFONIC ACID SODIUM		1 mt	60 days	T/T ADVANCE	looking for a RoHS certificate. RoHS is the res	2018/5/2	China（Taiwan, China）
fluconazol		10 Kg			10 Kg of fluconazol crystalline form micronized	2018/5/6	Egypt

Register as Visitor to CPhI China 2018!

Previous:Review of New Policies of Chinese Medical Reform

Next:Coeliac UK, Innovate UK launch research competition

Research and Application of Artemisia Argyi

XiaonishaAugust 12, 2024

Mugwort, also known as fragrant mugwort or Artemisia argyi, is a herbaceous plant belonging to the Compositae family.

Research Progress on the Application of Biologics in Pediatric Asthma

XiaomichongJuly 19, 2024

Research Progress on the Pharmacological Effects and New Drug Forms of Artemisinin and Its Derivatives

XiaomichongJuly 19, 2024

Urgent Sourcing Needs of【en-CPhI.cn】2018.05.14 | Pharmasources.com

Research and Development Status and Progress of Antibody Technology (Part Ⅱ)

XiaomichongJuly 18, 2024

Antibody-based biological therapeutic drugs have been playing an increasingly important role in biopharmaceuticals due to their strong targeting, good specificity, and significant therapeutic effects.

Urgent Sourcing Needs of【en-CPhI.cn】2018.05.14

Related News

Research and Application of Artemisia Argyi

Research Progress on the Application of Biologics in Pediatric Asthma

Research Progress on the Pharmacological Effects and New Drug Forms of Artemisinin and Its Derivatives

Research and Development Status and Progress of Antibody Technology (Part Ⅱ)

You may like
More>>

Urgent Sourcing Needs of【en-CPhI.cn】2018.05.14

Related News

Research and Application of Artemisia Argyi

Research Progress on the Application of Biologics in Pediatric Asthma

Research Progress on the Pharmacological Effects and New Drug Forms of Artemisinin and Its Derivatives

Research and Development Status and Progress of Antibody Technology (Part Ⅱ)

You may likeMore>>

You may like
More>>